Lobby organisation
European Organisation for Research and Treatment of Cancer
NGO or non-profit · Health & pharma · HQ: Belgium · Transparency Register entry
As of 7 November 2026, European Organisation for Research and Treatment of Cancer appears in 7 declared MEP meetings (7 different MEPs), most often with Renew Europe.
In their own words
“The European Organisation for Research and Treatment of Cancer (EORTC) has delivered investigator driven, changing practice clinical trials since 1962. Its mission is to improve survival and quality of life of cancer patients. The EORTC is a not-for-profit independent organisation performing multidisciplinary clinical research activities across tumor types.”
Read the rest of the statementShow less of the statement
“The EORTC aims to improve the standard of cancer treatment through the testing of more effective therapeutic strategies based on drugs, surgery and/or radiotherapy that are already in use. EORTC’s activities involve on a voluntary basis more than 3000 medical doctors and scientists from some 900 university hospitals in 35 countries. EORTC clinical trials are involving several thousands of cancer patients on a yearly basis. The EORTC operates on an independent basis, and in this capacity is able to work in partnership with the pharmaceutical industry in evaluating innovative molecules.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 7 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2026. Bar length is relative to its busiest year (4 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 7 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 22 Jul 2026 | Sophie Wilmès | Brain Cancer |
| 3 Jun 2026 | Tomislav Sokol | Health Policy |
| 28 May 2026 | Wouter Beke | EU Biotech Act I |
| 25 Mar 2026 | Vlad Vasile-Voiculescu | Intro meeting |
| 26 Mar 2025 | Tilly Metz | Cancer, public health research |
| 6 Mar 2025 | Olivier Chastel | Politique de santé de l'Union européenne - Optimisation des traitements |
| 4 Mar 2025 | Romana Jerković | Treatment Optimization in Oncology |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.